BORGESE, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 278
EU - Europa 254
AS - Asia 169
AF - Africa 17
OC - Oceania 13
SA - Sud America 1
Totale 732
Nazione #
US - Stati Uniti d'America 277
IT - Italia 96
VN - Vietnam 55
SG - Singapore 45
CN - Cina 42
GB - Regno Unito 39
SE - Svezia 26
DE - Germania 22
AT - Austria 19
IN - India 17
AU - Australia 12
IE - Irlanda 11
RU - Federazione Russa 7
FR - Francia 6
ZA - Sudafrica 6
FI - Finlandia 5
NL - Olanda 5
TG - Togo 5
BG - Bulgaria 4
ID - Indonesia 4
BE - Belgio 3
CI - Costa d'Avorio 3
DK - Danimarca 3
EE - Estonia 3
JO - Giordania 3
NG - Nigeria 3
CH - Svizzera 2
JP - Giappone 2
UA - Ucraina 2
BR - Brasile 1
CA - Canada 1
GR - Grecia 1
KR - Corea 1
NZ - Nuova Zelanda 1
Totale 732
Città #
Singapore 40
Fairfield 32
Bologna 31
Ashburn 28
Dong Ket 28
Southend 26
Chandler 25
Santa Clara 17
Seattle 17
Vienna 17
Milan 15
Ann Arbor 13
Wilmington 13
Cambridge 12
Dublin 11
Woodbridge 11
Adelaide 10
Boardman 10
Houston 9
Beijing 8
Princeton 6
Amsterdam 5
Lomé 5
New York 5
Turin 5
Bhubaneswar 4
Ferrara 4
Helsinki 4
Hyderabad 4
Jakarta 4
Johannesburg 4
Lunano 4
Nanjing 4
Sofia 4
Abeokuta 3
Abidjan 3
Amman 3
Berlin 3
Bremen 3
Brussels 3
Catania 3
Changsha 3
Falkenstein 3
Lambeth 3
Los Angeles 3
Paris 3
Westminster 3
Casalecchio di Reno 2
Cincinnati 2
City of Westminster 2
Copenhagen 2
Florence 2
Guangzhou 2
Hebei 2
Maruggio 2
Miami 2
Moscow 2
Padova 2
Pavia 2
Phoenix 2
Reggio Emilia 2
Spino d'Adda 2
Valsamoggia 2
Atlanta 1
Auckland 1
Bern 1
Budrio 1
Chengdu 1
Chennai 1
Dearborn 1
Falls Church 1
Frankfurt am Main 1
Handan 1
Jinan 1
Lappeenranta 1
Melbourne 1
Mestre 1
Munich 1
Ningbo 1
Nuremberg 1
Parma 1
Quanzhou 1
Redwood City 1
Saint Petersburg 1
San Diego 1
San Francisco 1
Seoul 1
Shenzhen 1
Sydney 1
Tokyo 1
Toronto 1
Toyama 1
Washington 1
Zhengzhou 1
Totale 537
Nome #
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 175
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 156
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 132
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 117
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 69
Age‐adjusted D‐dimer, clinical pre‐test probability‐adjusted D‐dimer, and whole leg ultrasound in ruling out suspected proximal and calf deep venous thrombosis 31
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 31
Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs. 30
Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital 25
Totale 766
Categoria #
all - tutte 2.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 0 0 15 12 17 6 7 2
2020/202194 11 0 2 1 9 1 1 0 4 5 1 59
2021/202268 3 4 3 10 7 3 2 3 3 6 14 10
2022/2023139 10 18 6 18 15 10 4 9 29 3 11 6
2023/2024149 7 7 6 6 4 12 8 18 8 22 18 33
2024/2025175 20 46 34 26 33 16 0 0 0 0 0 0
Totale 766